Biotech · Private company
SignPath Pharma, Inc.
Track this companyFree. Adds SignPath Pharma, Inc. to your Dealase workspace and tells you when its record changes.
Clinical trials11 recruiting or active
Pipeline programs4From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline4
- Treatment Period 1Phase 2 · GlioblastomaClinicalTrials.gov · fetched Nov 12, 2026
- Treatment Period 2Phase 2 · GlioblastomaClinicalTrials.gov · fetched Nov 12, 2026
- Treatment Period 3Phase 2 · GlioblastomaClinicalTrials.gov · fetched Nov 12, 2026
- Treatment Period 4aPhase 2 · GlioblastomaClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials1
- Study of Liposomal Curcumin in Combination With RT and TMZ in Patients With Newly Diagnosed High-Grade GliomasPHASE1_PHASE2 · RECRUITING · started Mar 3, 2023ClinicalTrials.gov NCT05768919 · fetched Nov 12, 2026